about
Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire d...
Read More
21.27
1.79
(9.19%)
2.5M
XNAS Volume
High volume+gain today
XNAS 22 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Graphite Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..